BIOMAT Database Logo BIOMAT Database Logo

Diarylaniline derivatives as a distinct class of HIV-1 non-nucleoside reverse transcriptase inhibitors. 2010

Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Beijing Institute of Pharmacology and Toxicology, 27 Taiping Road, Beijing 100850, China.

By using structure-based drug design and isosteric replacement, diarylaniline and 1,5-diarylbenzene-1,2-diamine derivatives were synthesized and evaluated against wild type HIV-1 and drug-resistant viral strains, resulting in the discovery of diarylaniline derivatives as a distinct class of next-generation HIV-1 non-nucleoside reverse transcriptase inhibitor (NNRTI) agents. The most promising compound 37 showed significant EC(50) values of 0.003-0.032 microM against HIV-1 wild-type strains and of 0.005-0.604 microM against several drug-resistant strains. Current results also revealed important structure-activity relationship (SAR) conclusions for diarylanilines and strongly support our hypothesis that an NH(2) group on the central benzene ring ortho to the aniline moiety is crucial for interaction with K101 of the NNRTI binding site in HIV-1 RT, likely by forming H-bonds with K101. Furthermore, molecular modeling studies with molecular mechanism/general Born surface area (MM/GBSA) technology demonstrated the rationality of our hypothesis.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006860 Hydrogen Bonding A low-energy attractive force between hydrogen and another element. It plays a major role in determining the properties of water, proteins, and other compounds. Hydrogen Bonds,Bond, Hydrogen,Hydrogen Bond
D000814 Aniline Compounds Compounds that include the aminobenzene structure. Phenylamine,Phenylamines,Anilines,Compounds, Aniline
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse

Related Publications

Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Discovery of Phenylaminopyridine Derivatives as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors.
August 2012, ACS medicinal chemistry letters,
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Difluoromethylbenzoxazole pyrimidine thioether derivatives: a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
December 2011, Journal of medicinal chemistry,
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Novel Cyclopropyl-Indole Derivatives as HIV Non-Nucleoside Reverse Transcriptase Inhibitors.
June 2012, ACS medicinal chemistry letters,
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1.
February 2004, Journal of medicinal chemistry,
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
1,2,3-Thiadiazole thioacetanilides as a novel class of potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
October 2008, Bioorganic & medicinal chemistry letters,
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Synthesis of novel uracil non-nucleoside derivatives as potential reverse transcriptase inhibitors of HIV-1.
November 2009, Archiv der Pharmazie,
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
November 2022, Molecules (Basel, Switzerland),
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Next-generation HIV-1 non-nucleoside reverse transcriptase inhibitors.
February 2006, Current opinion in investigational drugs (London, England : 2000),
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Arylsulfone-based HIV-1 non-nucleoside reverse transcriptase inhibitors.
December 2013, Future medicinal chemistry,
Bingjie Qin, and Xingkai Jiang, and Hong Lu, and Xingtao Tian, and Florent Barbault, and Li Huang, and Keduo Qian, and Chin-Ho Chen, and Rong Huang, and Shibo Jiang, and Kuo-Hsiung Lee, and Lan Xie
Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
February 2006, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!